Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor

Mol Pharmacol. 1998 Feb;53(2):283-94. doi: 10.1124/mol.53.2.283.

Abstract

We report that preapplication of ivermectin, in the micromolar range, strongly enhances the subsequent acetylcholine-evoked current of the neuronal chick or human alpha7 nicotinic acetylcholine receptors reconstituted in Xenopus laevis oocytes and K-28 cells. This potentiation does not result from nonspecific Cl- currents. The concomitant increase in apparent affinity and cooperativity of the dose-response curve suggest that ivermectin acts as a positive allosteric effector. This interpretation is supported by the observation of an increase in efficiency of a partial agonist associated with the potentiation and by the differential effect of ivermectin on mutants within the M2 channel domain. Ivermectin effects reveal a novel allosteric site for pharmacological agents on neuronal alpha7 nicotinic acetylcholine receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation / drug effects
  • Animals
  • Anthelmintics / pharmacology
  • Binding Sites
  • Cell Line
  • Cell Membrane / chemistry
  • Chickens
  • Chloride Channels / physiology
  • Humans
  • Ion Channel Gating
  • Ivermectin / pharmacology*
  • Membrane Potentials
  • Models, Molecular
  • Neurons / drug effects
  • Neurons / physiology
  • Nicotinic Agonists / pharmacology
  • Oocytes
  • Point Mutation
  • Receptors, Nicotinic / chemistry
  • Receptors, Nicotinic / drug effects*
  • Recombinant Proteins
  • Solubility
  • Structure-Activity Relationship
  • Transfection
  • Xenopus laevis
  • alpha7 Nicotinic Acetylcholine Receptor

Substances

  • Anthelmintics
  • Chloride Channels
  • Chrna7 protein, human
  • Nicotinic Agonists
  • Receptors, Nicotinic
  • Recombinant Proteins
  • alpha7 Nicotinic Acetylcholine Receptor
  • Ivermectin